Literature DB >> 5912298

Hemodynamic studies in beriberi heart disease.

M Akbarian, N A Yankopoulos, W H Abelmann.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5912298     DOI: 10.1016/0002-9343(66)90016-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  17 in total

1.  A patient with severe lactic acidosis and rapidly evolving multiple organ failure: a case of shoshin beri-beri.

Authors:  J Kountchev; K Bijuklic; R Bellmann; M Joannidis
Journal:  Intensive Care Med       Date:  2005-05-05       Impact factor: 17.440

2.  Cardiac and renal failure in a 38-year-old alcoholic.

Authors:  S Sinha; M S Norell; B S Nanda
Journal:  Postgrad Med J       Date:  1995-05       Impact factor: 2.401

3.  Hemodynamic consequences of femoral arteriovenous bovine shunts.

Authors:  H J Fee; J A Levisman; J P Dickmeyer; A L Golding
Journal:  Ann Surg       Date:  1976-07       Impact factor: 12.969

4.  High Output Cardiac Failure.

Authors:  Inder S. Anand; Viorel G. Florea
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-04

5.  Shoshin beriberi: an underdiagnosed condition?

Authors:  J A Pang; A Yardumian; R Davies; D L Patterson
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

6.  Cobalt cardiomyopathy: clinical aspects.

Authors:  Y Morin; A Têtu; G Mercier
Journal:  Br Heart J       Date:  1971

7.  Shoshin beriberi: a rare diagnostic problem.

Authors:  J G Engbers; G P Molhoek; A C Arntzenius
Journal:  Br Heart J       Date:  1984-05

8.  Quebec beer-drinkers' cardiomyopathy: hemodynamic alterations.

Authors:  Y Morin
Journal:  Can Med Assoc J       Date:  1967-10-07       Impact factor: 8.262

9.  Treatment of congestive cardiomyopathy.

Authors:  W H Abelmann
Journal:  Postgrad Med J       Date:  1978-07       Impact factor: 2.401

10.  Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopathy.

Authors:  T J Regan; G E Levinson; H A Oldewurtel; M J Frank; A B Weisse; C B Moschos
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.